MedTrace Logo

Evaluation of the Irritation Potential of Sunscreen Products in Human Eyes

NCT02854137 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2018-12-12

No results posted yet for this study

Summary

Evaluation of the human eye irritation potential of a test sunscreen formulation.

Conditions

  • Sunscreening Agents

Interventions

DRUG

BAY987521

10 micro L of the appropriate test product is place into the lower conjunctival sac of the designated eye (Formulation code: Y49-103).

DRUG

Control

10 micro L of the appropriate controlled product is place into the lower conjunctival sac of the designated eye.

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-14
Primary Completion
2015-10-14
Completion
2015-10-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02854137 on ClinicalTrials.gov